Multivessel Disease and Severe Carotid Stenosis: How to Proceed

Myocardial revascularization surgery (CABG) is the most frequent of all cardiovascular surgeries and is still the gold standard to treat multivessel disease.  Between 6 and 8% of these patients present concomitant carotid stenosis and it is associated with increased peri and post procedural stroke rates during and after surgery.

Lesión de múltiples vasos y enfermedad carotidea severa ¿Cómo proceder?

To prevent carotid stenosis, either PCI or endarterectomy can be carried out, prior CABG or simultaneously.


Read also: End of Discussion on the Impact of Pacemaker After TAVR?”


All data come from case series with different inclusion criteria or end point definitions, which is why no definite evidence from randomized and controlled studies show any advantage of endarterectomy over CABG, neither simultaneous nor staged, vs. isolated CABG.

 

Patients with severe asymptomatic stenosis to the internal carotid – ≥80% according to ECST (European Carotid Surgery Trial), or ≥70% by ECG, according to NASCET (North American Symptomatic Carotid Endarterectomy Trial)- requiring CABG were randomized to synchronous endarterectomy + CABG vs. isolated CABG. Randomization was stratified by center, age, sex and modified Rankin scale. Primary end point was rate of stroke and death at 30 days.

 

Between 2010 and 2014 a total 129 patients in 17 centers of Germany and the Czech Republic were enrolled. Poor recruitment and funding terminated enrolment earlier.


Read also: With Absorb Out, New Resorbable Scaffolds Have Come onto the Market”.


At 30 days, the rate of any stroke or death was 12/65 (18.5%) in those receiving synchronous endarterectomy + CABG compared to 6/62 (9.7%) in patients undergoing isolated CABG (absolute risk reduction 8.8%; p=0.12).

 

Secondary end points saw no significant difference between the groups both at 30 days and a year, even though there was a tendency in favor of isolated CABG.

 

Conclusion

These outcomes are not definite, due to the study’s low statistical power, but combining endarterectomy and CABG in the same procedure seems unlikely to be the best treatment strategy. The 5 year follow up is still ongoing. 

 

Editorial Comment

Carotid stenting is an alternative to endarterectomy, though most studies have shown higher periprocedural stroke rate with stenting (mostly minor stroke). This happens mostly in elderly men, who typically present with both concomitant problems. 

 

A systematic version of cohort studies has showed a stroke and death rate of 9.1% with PCI and staged CABG. Some observational studies have also favored this strategy even more.  The problem is the need of at least one month of dual antiaggregation, which postpones surgery and exposes patients to coronary events while they wait.

 

Another possible strategy is to perform PCI and, if there were no complications, take patients straight to surgery, right after the cath lab. The procedure has to be carried out without dual antiaggregation, and after surgery, if there is no bleeding, the patient can receive clopidogrel by nasogastric tube. There is no randomized evidence for this last recommendation.

 

Original title: Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting. A Randomized Clinical Trial.

Reference: Christian Weimar et al. Stroke. 2017 Oct;48(10):2769-2775.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...